Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Momparler, Richard L."'
Publikováno v:
In Leukemia Research August 2012 36(8):1049-1054
Publikováno v:
In Leukemia Research 2011 35(1):110-118
Autor:
Karahoca Metin, Momparler Richard L
Publikováno v:
Clinical Epigenetics, Vol 5, Iss 1, p 3 (2013)
Abstract 5-Aza-2′-deoxycytidine (5-AZA-CdR, decitabine), an epigenetic drug that inhibits DNA methylation, is currently used to treat myelodysplastic syndrome (MDS), and is under investigation for treating acute myeloid leukemia (AML) and other mal
Externí odkaz:
https://doaj.org/article/2a331392f8384b04bc8e7e856b2748cb
Publikováno v:
In Leukemia Research 2003 27(5):437-444
Publikováno v:
Epigenomes; Jun2021, Vol. 5 Issue 2, p1-6, 6p
Publikováno v:
Cancer Cell International, Vol 8, Iss 1, p 16 (2008)
Abstract Background Most patients with advanced Ewing's sarcoma (EWS) respond poorly to conventional chemotherapy, indicating the need for new treatment approaches. Epigenetic events, such as promoter hypermethylation and chromatin histone deacetylat
Externí odkaz:
https://doaj.org/article/dc2560b99f744875bd013082c976eb29
Autor:
Momparler Richard L, Bernstein Mark L, Hurtubise Annie, Momparler Louise F, Chabot Guy G, Raynal Noël JM, Lemaire Maryse
Publikováno v:
BMC Cancer, Vol 8, Iss 1, p 128 (2008)
Abstract Background The inactivation of tumor suppressor genes (TSGs) by aberrant DNA methylation plays an important role in the development of malignancy. Since this epigenetic change is reversible, it is a potential target for chemotherapeutic inte
Externí odkaz:
https://doaj.org/article/7ee13706d9cc4efaa0f5c367b240979e
Publikováno v:
In Analytical Biochemistry 15 May 2000 281(1):55-61
Autor:
Momparler, Richard L.1 richard.l.momparler@umontreal.ca
Publikováno v:
Pharmaceuticals (14248247). Aug2012, Vol. 5 Issue 8, p875-881. 7p. 1 Diagram, 1 Chart.
Autor:
Momparler, Richard L1
Publikováno v:
Oncogene. 9/29/2003 Review, Vol. 22 Issue 42, p6479-6483. 5p.